Ken O. Awuondo

发表

Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya

B. Ogutu, J. Chretien, W. O'Meara, 2007, Malaria Journal.

Temporal Association of Acute Hepatitis A and Plasmodium falciparum Malaria in Children

K. Marsh, M. Bonten, P. Sasi, 2011, PloS one.

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

M. Demoitié, K. Marsh, C. Drakeley, 2008, The New England journal of medicine.

Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial

S. Kariuki, J. Berkley, G. Fegan, 2016, The Lancet. Global health.

Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study

B. Lowe, A. Olotu, P. Njuguna, 2017, PloS one.

Use of Rapid Diagnostic Tests in Malaria School Surveys in Kenya: Does their Under-performance Matter for Planning Malaria Control?

R. Snow, A. Noor, S. Brooker, 2012, The American journal of tropical medicine and hygiene.

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya

R. Snow, K. Maitland, J. Scott, 2019, BMC Medicine.

Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study

R. Snow, A. Noor, B. Lowe, 2016, PLoS medicine.

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.

Kevin Marsh, Juliana K. Wambua, Philip Bejon, 2013, The New England journal of medicine.

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

K. Marsh, C. Drakeley, A. Olotu, 2011, The Lancet. Infectious diseases.

In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa.

M. Pirmohamed, A. Nzila, B. Lowe, 2009, The Journal of infectious diseases.

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya

S. Hoffman, B. Lowe, K. Marsh, 2015, Malaria Journal.

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

S. Hoffman, B. Lowe, K. Marsh, 2014, Front. Microbiol..

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya

S. Hoffman, B. Lowe, K. Marsh, 2015, Malaria Journal.

Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

K. Marsh, C. Drakeley, A. Olotu, 2010, PloS one.

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

M. Demoitié, K. Marsh, A. Olotu, 2008, The New England journal of medicine.